Ophiomics
PrivateLast Round
Series A
Jan 18, 2023
Total Funding Raised
$1.29M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ophiomics operates in Healthcare & Life Sciences and is based in Lisbon. Its latest recorded funding round was a Series A round in January 2023.
Ophiomics is a biotechnology company that develops AI-powered in vitro diagnostic solutions and precision medicine tools for liver cancer management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ophiomics Comparables
Compare Ophiomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Helio Genomics | 78% | |
| Glycotest, Inc. | 77% | |
| Mursla Bio | 77% |
For institutional investors. Book with your work email.
Ophiomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 18, 2023 | ||||
| Seed | Jun 9, 2021 | ||||
| Grant | Sep 28, 2020 | ||||
| Grant | May 1, 2020 | ||||
| Grant | Aug 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ophiomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| European Commission | Grant |
| BlueCrow Capital | Series A |
| EIC Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 1703% from 33 to 595.
- May 16, 2026
Monthly visitors increased 36% MoM.
For institutional investors. Book with your work email.
Ophiomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ophiomics's valuation, stock price, and market status.
Is Ophiomics a public or private company?
Ophiomics is a private company.
What is the current stock price of Ophiomics?
Ophiomics is a private company, so its shares have no public market price. Caplight tracks Ophiomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ophiomics worth (valuation)?
Valuation information for Ophiomics is not publicly available.
Can I buy Ophiomics stock?
Ophiomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ophiomics's last funding round?
Ophiomics's most recent funding round was Series A on January 18, 2023.
Who are the main investors in Ophiomics?
Key investors in Ophiomics include BlueCrow Capital, EIC Fund.
Will Ophiomics IPO soon?
No public IPO plans have been announced for Ophiomics.
How can I track Ophiomics secondary market activity?
Caplight tracks bids, offers, and trades in Ophiomics's shares on secondary markets.